Literature DB >> 19647361

Kinetic study of von Willebrand factor self-aggregation induced by ristocetin.

Enrico Di Stasio1, Federica Romitelli, Stefano Lancellotti, Alessandro Arcovito, Bruno Giardina, Raimondo De Cristofaro.   

Abstract

Von Willebrand factor (VWF) is a multimeric glycoprotein present in circulating blood and in secretory granules of endothelial cells and platelets. VWF is sensitive to hydrodynamic shear stress that promotes conformational changes, rendering it able to interact with subendothelial proteins and platelets, thus promoting primary haemostasis. Likewise, the binding of the glycopeptide antibiotic ristocetin to VWF triggers hemostatically relevant conformational transitions. These changes reveal both the interaction site for platelet receptor GpIbalpha and the Tyr1605-Met1606 peptide bond, which is cleaved by the regulatory metalloprotease ADAMTS-13. In this study we investigated by a combined approach of light scattering spectroscopy and turbidimetry the ability of VWF to self-associate in solution in the presence of ristocetin and in the absence of any protein adsorbing surface. Micro- and macro-aggregates induced by ristocetin, have been characterized under static conditions in the early stage of formation and on a longer time scale (up to 10 h). These findings show that VWF multimers form supramolecular structures favoring platelet trapping not only under high shear stress or interaction with external surfaces, but also in solution under static conditions when the conformational state of the protein is changed only by chemical potential of allosteric effectors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647361     DOI: 10.1016/j.bpc.2009.07.002

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  5 in total

1.  A bio-inspired method for direct measurement of local wall shear rates with micrometer localization using the multimeric protein von Willebrand factor as sensor molecule.

Authors:  Klaus Bonazza; Bernhard Scheichl; Johannes Frank; Hanspeter Rottensteiner; Gerald Schrenk; Gernot Friedbacher; Peter L Turecek; Friedrich Scheiflinger; Günter Allmaier
Journal:  Biomicrofluidics       Date:  2017-08-30       Impact factor: 2.800

2.  Ristocetin-induced self-aggregation of von Willebrand factor.

Authors:  Massimiliano Papi; Giuseppe Maulucci; Marco De Spirito; Mauro Missori; Giuseppe Arcovito; Stefano Lancellotti; Enrico Di Stasio; Raimondo De Cristofaro; Alessandro Arcovito
Journal:  Eur Biophys J       Date:  2010-06-30       Impact factor: 1.733

3.  Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains.

Authors:  Monica Sacco; Stefano Lancellotti; Mattia Ferrarese; Francesco Bernardi; Mirko Pinotti; Maira Tardugno; Erica De Candia; Leonardo Di Gennaro; Maria Basso; Betti Giusti; Massimiliano Papi; Giordano Perini; Giancarlo Castaman; Raimondo De Cristofaro
Journal:  Blood Adv       Date:  2020-07-28

Review 4.  The unfolded von Willebrand factor response in bloodstream: the self-association perspective.

Authors:  Hailong Yuan; Ning Deng; Songmei Zhang; Yange Cao; Qiong Wang; Xin Liu; Qing Zhang
Journal:  J Hematol Oncol       Date:  2012-10-15       Impact factor: 17.388

Review 5.  Proteolytic processing of von Willebrand factor by adamts13 and leukocyte proteases.

Authors:  Stefano Lancellotti; Maria Basso; Raimondo De Cristofaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.